Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

GABAA R beta1 Inhibitors

Santa Cruz Biotechnology now offers a broad range of GABAA R β1 Inhibitors for use in various applications. GABAA receptors, particularly those incorporating the β1 subunit, are key components of the inhibitory neurotransmission system within the central nervous system. These receptors are primarily responsible for mediating the effects of gamma-aminobutyric acid (GABA), the brain's principal inhibitory neurotransmitter, which plays a critical role in reducing neuronal excitability and maintaining the balance between excitation and inhibition. GABAA R β1 Inhibitors are essential tools in scientific research, allowing for the selective inhibition of these receptor subtypes to study their specific functions in neural signaling, synaptic transmission, and overall brain activity. By inhibiting GABAA R β1, researchers can explore how these receptors influence various physiological processes, including anxiety regulation, cognitive function, and motor control. These inhibitors are widely used in electrophysiological studies, behavioral research, and pharmacological experiments to better understand the role of GABAA receptors in neural circuit dynamics and the broader implications of altered GABAergic signaling in neurological conditions. Additionally, GABAA R β1 Inhibitors are valuable in research focused on explaining the interactions between different subunits of GABAA receptors and their contributions to the modulation of inhibitory synaptic transmission. The availability of these inhibitors has significantly advanced research in neurobiology and neuroscience, providing critical insights into the intricate regulatory mechanisms of inhibitory neurotransmission. View detailed information on our available GABAA R β1 Inhibitors by clicking on the product name.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

SCS

3232-36-8sc-203375
50 mg
$105.00
(0)

SCS functions as a selective modulator of GABAA receptors, particularly engaging with the beta-1 subunit. Its unique molecular structure allows for specific hydrogen bonding interactions, enhancing receptor affinity and altering ion channel kinetics. The compound exhibits distinct electrostatic properties that influence its solubility and membrane permeability, facilitating targeted receptor engagement. Additionally, SCS demonstrates a nuanced impact on synaptic transmission dynamics, contributing to its overall efficacy in modulating neural activity.